FDA inspection
Shenzhen Hepalink Pharmaceutical Group Co., Ltd.: FDA inspection ending Jun 13, 2025
FDA inspection 1276175 · Voluntary Action Indicated (VAI) · Shenzhen
Key facts
| Inspection ID | 1276175 |
|---|---|
| Firm | Shenzhen Hepalink Pharmaceutical Group Co., Ltd. |
| FEI number | 3014772595 |
| Address | No. 1 Rongtian Road, Longgang District |
| City | Shenzhen |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Jun 13, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data